Effect of oral beta-alanine supplementation on muscle carnosine in patients with COPD: A double blind, placebo-controlled, randomized trial
J. De Brandt (Diepenbeek, Belgium), W. Derave (Ghent, Belgium), F. Vandenabeele (Diepenbeek, Belgium), J. Aumann (Hasselt, Belgium), L. Blancquaert (Ghent, Belgium), I. Everaert (Ghent, Belgium), M. Spruit (Diepenbeek, Belgium)
Source: Virtual Congress 2020 – Muscle, exercise capacity and symptoms of chronic lung disease: a physio update
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. De Brandt (Diepenbeek, Belgium), W. Derave (Ghent, Belgium), F. Vandenabeele (Diepenbeek, Belgium), J. Aumann (Hasselt, Belgium), L. Blancquaert (Ghent, Belgium), I. Everaert (Ghent, Belgium), M. Spruit (Diepenbeek, Belgium). Effect of oral beta-alanine supplementation on muscle carnosine in patients with COPD: A double blind, placebo-controlled, randomized trial. 4748
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Short-term effect of a single dose of inhaled procaterol on exercise performance in COPD: a randomized, double blind, placebo-controlled, crossover trial Source: Annual Congress 2008 - Physiological response to exercise performance Year: 2008
Randomised double blind placebo controlled trial of selenium supplementation in adult asthma Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006
Dietary nitrate supplementation and exercise tolerance in chronic heart failure: A double-blind, randomized, placebo-controlled, crossover trial Source: International Congress 2016 – Clinical exercise physiology in health and disease Year: 2016
Efficacy of a synbiotic supplementation in the prevention of respiratory and intestinal diseases in children: A randomized, double-blind placebo controlled study Source: Annual Congress 2010 - Childhood pneumonia: from prevention to complications Year: 2010
A double-blind randomised controlled trial of protein supplementation to enhance exercise capacity in COPD during pulmonary rehabilitation: a pilot study Source: ERJ Open Res, 7 (1) 00077-2021; 10.1183/23120541.00077-2021 Year: 2021
A randomised, placebo-controlled trial of inhaled mannitol in patients with bronchiectasis Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis Year: 2008
Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial Source: ERJ Open Res, 7 (4) 00475-2021; 10.1183/23120541.00475-2021 Year: 2021
Efficacy and safety of revefenacin (REV), a long-acting muscarinic antagonist for nebulization: results of replicate randomized, double-blind, placebo-controlled, parallel-group phase 3 trials in participants with moderate to very severe COPD Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017
Substitution of vitamin D in patients with moderate to severe persistent asthma: A randomized, placebo-controlled pilot study Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma Year: 2012
Effects of a concomitant therapy with Cineole (Eucalyptole) on exacerbation rate in COPD: A placebo-controlled double-blind trial Source: Annual Congress 2010 - COPD exacerbation Year: 2010
RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations Source: Virtual Congress 2021 – ALERT: COPD Year: 2021
Umeclidinium in patients with COPD: a randomised, placebo-controlled study Source: Eur Respir J 2014; 43: 72-81 Year: 2004
The effect of bronchodilators in the exercise capacity and thoracoabdominal mechanics of subjects with bronchiectasis: a randomized crossover, double-blinded, placebo-controlled trial Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases Year: 2020
Detrimental effects of β-blockers in COPD: a concern for nonselective β-blockers: a randomised, placebo controlled, cross-over study Source: Eur Respir J 2003; 22: Suppl. 45, 49s Year: 2003
Efficacy of a short course of oral prednisolone for acute preschool viral-wheeze: a double-blind randomised placebo-controlled trial with stratification for systemic eosinophil priming Source: Eur Respir J 2003; 22: Suppl. 45, 388s Year: 2003
Roflumilast in Asian patients with COPD: A randomised placebo-controlled trial Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
A double-blind double dummy randomised placebo-controlled cross-over design clinical trial of formoterol delivered by two different dry powder devices in prevention of bronchoconstriction induced by methacholine in mild to moderate persistent asthma in adult patients Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment Year: 2009
Vitamin E supplementation in the treatment of asthma: a randomised controlled trial Source: Eur Respir J 2003; 22: Suppl. 45, 104s Year: 2003
Effectiveness of influenza vaccination in asthmatic children: randomised, double-blind, placebo-controlled trial Source: Eur Respir J 2002; 20: Suppl. 38, 146s Year: 2002